These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12818458)

  • 21. Are we employing the most effective CA 125 and CA 19-9 cut-off values to detect endometriosis?
    Xavier P; Beires J; Belo L; Rebelo I; Martinez-de-Oliveira J; Lunet N; Barros H
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):254-5. PubMed ID: 15893865
    [No Abstract]   [Full Text] [Related]  

  • 22. Extremely elevated serum CA125 due to endometriosis.
    Kashyap RJ
    Aust N Z J Obstet Gynaecol; 1999 May; 39(2):269-70. PubMed ID: 10755799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between serum levels of CA 125 and follicular loss after laparoscopic cystectomy in women with ovarian endometrioma.
    Vicino M; Resta L; Scioscia M; Marzullo A; Ceci O; Bettocchi S
    J Minim Invasive Gynecol; 2007; 14(2):223-7. PubMed ID: 17368261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma urocortin levels in the diagnosis of ovarian endometriosis.
    Florio P; Reis FM; Torres PB; Calonaci F; Toti P; Bocchi C; Linton EA; Petraglia F
    Obstet Gynecol; 2007 Sep; 110(3):594-600. PubMed ID: 17766605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of serum CA 125 and D-dimer levels associated with rupture of ovarian endometrioma.
    Uharcek P; Mlyncek M; Ravinger J
    Int J Biol Markers; 2007; 22(3):203-5. PubMed ID: 17922464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
    Tsao KC; Hong JH; Wu TL; Chang PY; Sun CF; Wu JT
    J Clin Lab Anal; 2007; 21(3):193-6. PubMed ID: 17506483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncological markers CA-125, CA 19-9 and endometriosis.
    Fiala L; Bob P; Raboch J
    Medicine (Baltimore); 2018 Dec; 97(51):e13759. PubMed ID: 30572523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cyclooxygenase-2 in eutopic endometrium and ovarian endometriotic tissue in women with severe endometriosis.
    Cho S; Park SH; Choi YS; Seo SK; Kim HY; Park KH; Cho DJ; Lee BS
    Gynecol Obstet Invest; 2010; 69(2):93-100. PubMed ID: 20068324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of advanced endometriosis with extremely high CA 125 and moderately elevated CA 15-3 levels.
    Canda MT; Demir N; Sezer O; Doganay L
    Clin Exp Obstet Gynecol; 2008; 35(3):231-2. PubMed ID: 18754302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CA-125: a biomarker put to the test.
    Schmidt C
    J Natl Cancer Inst; 2011 Sep; 103(17):1290-1. PubMed ID: 21852262
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated serum CA 19-9 with adnexal mass: is it always an ovarian malignancy?
    Chew KT; Zakaria IA; Abu MA; Ahmad MF; Hing EY; Abdul Ghani NA
    Horm Mol Biol Clin Investig; 2018 Mar; 34(3):. PubMed ID: 29584612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions.
    Somigliana E; Viganò P; Tirelli AS; Felicetta I; Torresani E; Vignali M; Di Blasio AM
    Hum Reprod; 2004 Aug; 19(8):1871-6. PubMed ID: 15218003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum interleukin-8 levels are elevated in patients with ovarian endometrioma.
    Ohata Y; Harada T; Miyakoda H; Taniguchi F; Iwabe T; Terakawa N
    Fertil Steril; 2008 Oct; 90(4):994-9. PubMed ID: 18635170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis.
    Harada T; Kubota T; Aso T
    Fertil Steril; 2002 Oct; 78(4):733-9. PubMed ID: 12372448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing endometrioma management: Diagnostic biomarkers and predictive outcomes in Ruptured vs. Non-Ruptured cases.
    Erturun AG; Dilbaz B; Aksan A; Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():167-172. PubMed ID: 38875853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Explosive rise of serum CA 125 following the rupture of ovarian endometrioma.
    Johansson J; Santala M; Kauppila A
    Hum Reprod; 1998 Dec; 13(12):3503-4. PubMed ID: 9886540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of CA19-9 and CA125 in histological subtypes of epithelial ovarian tumors and ovarian endometriosis.
    Nakagawa N; Koda H; Nitta N; Nakahara Y; Uno J; Hashimoto T; Nakahori T; Hasegawa M; Kataoka M
    Acta Med Okayama; 2015; 69(4):227-35. PubMed ID: 26289914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration.
    Koninckx PR; Meuleman C; Oosterlynck D; Cornillie FJ
    Fertil Steril; 1996 Feb; 65(2):280-7. PubMed ID: 8566249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association of ovarian tumors with CA-125].
    Martínez-Acosta JE; Olguín-Cruces VA
    Rev Med Inst Mex Seguro Soc; 2016; 54 Suppl 3():S230-S237. PubMed ID: 27855043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of urocortin and Ca-125 in the diagnosis of endometrioma.
    Tokmak A; Ugur M; Tonguc E; Var T; Moraloğlu O; Ozaksit G
    Arch Gynecol Obstet; 2011 May; 283(5):1075-9. PubMed ID: 20480172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.